452 related articles for article (PubMed ID: 22356512)
1. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
[TBL] [Abstract][Full Text] [Related]
2. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database.
Guijarro R; Montes J; San Román C; Arcelus JI; Barillari G; Granero X; Monreal M
Thromb Haemost; 2011 Apr; 105(4):610-5. PubMed ID: 21174008
[TBL] [Abstract][Full Text] [Related]
4. Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Curr Med Res Opin; 2011 Feb; 27(2):423-9. PubMed ID: 21192759
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
6. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.
Cohn DM; Hermanides J; DeVries JH; Kamphuisen PW; Kuhls S; Homering M; Hoekstra JB; Lensing AW; Büller HR
Thromb Haemost; 2012 Feb; 107(2):225-31. PubMed ID: 22187097
[TBL] [Abstract][Full Text] [Related]
9. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
Kwong LM
Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
[TBL] [Abstract][Full Text] [Related]
11. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
12. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
15. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
[TBL] [Abstract][Full Text] [Related]
16. Are bilateral total joint arthroplasty patients at a higher risk of developing pulmonary embolism following total hip and knee surgery?
Yeager AM; Ruel AV; Westrich GH
J Arthroplasty; 2014 May; 29(5):900-2. PubMed ID: 24360492
[TBL] [Abstract][Full Text] [Related]
17. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice.
Pedersen AB; Mehnert F; Sorensen HT; Emmeluth C; Overgaard S; Johnsen SP
Bone Joint J; 2014 Apr; 96-B(4):479-85. PubMed ID: 24692614
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty.
Baser O
Am J Manag Care; 2011 Feb; 17(1 Suppl):S6-8. PubMed ID: 21517654
[TBL] [Abstract][Full Text] [Related]
19. Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review.
Kwong LM; Kistler KD; Mills R; Wildgoose P; Klaskala W
Expert Opin Pharmacother; 2012 Feb; 13(3):333-44. PubMed ID: 22220855
[TBL] [Abstract][Full Text] [Related]
20. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
Wu PK; Chen CF; Chung LH; Liu CL; Chen WM
Thromb Res; 2014 May; 133(5):719-24. PubMed ID: 24593913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
